229
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Clinical analysis and outcomes of amyotrophic lateral sclerosis with demyelinating polyneuropathy

, , , , , & show all
Pages 125-131 | Received 21 Jul 2011, Accepted 24 Sep 2011, Published online: 03 Jan 2012

References

  • Hammad M, Silva A, Glass J, Sladky JT, Benatar M. Clinical, electrophysiologic, and pathologic evidence for sensory abnormalities in ALS. Neurology. 2007;69:2236–42.
  • de Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve. 2000;23:344–52.
  • Feinberg DM, Preston DC, Shefner JM, Logigian EL. Amplitude-dependent slowing of conduction in amyotrophic lateral sclerosis and polyneuropathy. Muscle Nerve. 1999;22:937–40.
  • Rajabally YA, Jacob S. Chronic inflammatory demyelinating polyneuropathy-like disorder associated with amyotrophic lateral sclerosis. Muscle Nerve. 2008;38:855–60.
  • Echaniz-Laguna A, Degos B, Mohr M, Kessler R, Urban-Kraemer E, Tranchant C. A study of three patients with amyotrophic lateral sclerosis and a polyneuropathy resembling CIDP. Muscle Nerve. 2006;33:356–62.
  • Brooks BR, Miller RG, Swash M, Munsat TL; World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–9.
  • Hughes RA, Bouche P, Cornblath DR, Evers E, Hadden RD, Hahn A, . European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol. 2006;13:326–32.
  • de Carvalho M, Dengler R, Eisen A, England JD, Kaji R, Kimura J, . Electrodiagnostic criteria for diagnosis of ALS. Clin Neurophysiol. 2008;119:497–503.
  • Adachi T, Imaoka K, Shirasawa A, Yamaguchi S, Kobayashi S. A case of hereditary motor and sensory neuropathy with pyramidal tract sign, optic nerve atrophy and mental retardation. Rinsho Shinkeigaku. 1998;38:1037–41.
  • Zhou L, Piolo EP. Familial ALS with SOD1 mutation misdiagnosed with polyradiculopathy and myopathy. Amyotroph Lateral Scler. 2009;10:476–8.
  • Thomas PK, Claus D, Jaspert A, Workman JM, King RH, Larner AJ, . Focal upper limb demyelinating neuropathy. Brain. 1996;119:765–74.
  • Donofrio PD, Berger A, Brannagan TH 3rd, Bromberg MB, Howard JF, Latov N, . Consensus statement: the use of intravenous immunoglobulin in the treatment of neuromuscular conditions (report of the AANEM ad hoc committee). Muscle Nerve. 2009;40:890–900.
  • Mondelli M, Rossi A, Passero S, Guazzi GC. Involvement of peripheral sensory fibers in amyotrophic lateral sclerosis: electrophysiologic study of 64 cases. Muscle Nerve. 1993;16:166–72.
  • Preston DC, Shapiro BE. Basic nerve conduction studies. In: Preston DC, Shapiro BE, editors. Electromyography and neuromuscular disorders. Boston: Butterworth-Heinemann; 1998. pp 25–44.
  • de Carvalho M, Swash M. Nerve conduction studies in amyotrophic lateral sclerosis. Muscle Nerve. 2000;23:344–52.
  • Pestronk A, Adams RN, Cornblath D, Kuncl RW, Drachman DB, Clawson L. Patterns of serum IgM antibodies to GM1 and GD1a gangliosides in amyotrophic lateral sclerosis. Ann Neurol. 1989;25:98–102.
  • Yamazaki T, Suzuki M, Irie T, Watanabe T, Mikami H, Ono S. Amyotrophic lateral sclerosis associated with IgG anti-GalNAc-GD1a antibodies. Clin Neurol Neurosurg. 2008;110:722–4.
  • Yoshino H. Distribution of gangliosides in the nervous tissues recognized by axonal form of Guillain-Barré syndrome. Neuroimmunology. 1997;5:174–5.
  • Yuki N, Ho TW, Tagawa Y, Koga M, Li CY, Hirata K, . Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China. J Neurol Sci. 1999;164:134–8.
  • Kusunoki S, Chiba A, Kon K, Ando S, Arisawa K, Tate A, . N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol. 1994;35:570–6.
  • Sharma KR, Cross J, Farronay O, Ayyar DR, Shebert RT, Bradley WG. Demyelinating neuropathy in diabetes mellitus. Arch Neurol. 2002;59:758–65.
  • Jawaid A, Salamone AR, Strutt AM, Murthy SB, Wheaton M, McDowell EJ, . ALS disease onset may occur later in patients with pre-morbid diabetes mellitus. Eur J Neurol. 2010;17:733–9.
  • Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, . Diabetic Polyneuropathies: Update on Research Definition, Diagnostic Criteria and Estimation of Severity. Diabetes Metab Res Rev. 2011 Jun 21. (Epub ahead of print)
  • Chiò A, Logroscino G, Hardiman O, Swingler R, Mitchell D, Beghi E, . Prognostic factors in ALS: a critical review. Amyotroph Lateral Scler. 2009;10:310–23.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.